Can we cure 50% of all multiple myeloma patients in the next five years?
Measuring treatment response rates in multiple myeloma
Topics in multiple myeloma discussed at ASCO 2016
Immunotherapy for the treatment of multiple myeloma
Highlights from EHA 2016 press briefings: POLLUX and EURO-SKI trials and BiTE antibodies